27 related articles for article (PubMed ID: 24446298)
1. Fabrication of Polymerase Chain Reaction Plastic Lab-on-a-Chip Device for Rapid Molecular Diagnoses.
Trinh KT; Zhang H; Kang DJ; Kahng SH; Tall BD; Lee NY
Int Neurourol J; 2016 May; 20(Suppl 1):S38-48. PubMed ID: 27230459
[TBL] [Abstract][Full Text] [Related]
2. Delineation of prognostic biomarkers in prostate cancer.
Dhanasekaran SM; Barrette TR; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta KJ; Rubin MA; Chinnaiyan AM
Nature; 2001 Aug; 412(6849):822-6. PubMed ID: 11518967
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
[TBL] [Abstract][Full Text] [Related]
4. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.
Schlomm T; Chun FKh; Erbersdobler A
Methods Mol Biol; 2010; 664():177-89. PubMed ID: 20690063
[TBL] [Abstract][Full Text] [Related]
5. A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.
Agell L; Hernández S; Nonell L; Lorenzo M; Puigdecanet E; de Muga S; Juanpere N; Bermudo R; Fernández PL; Lorente JA; Serrano S; Lloreta J
Am J Pathol; 2012 Nov; 181(5):1585-94. PubMed ID: 23083832
[TBL] [Abstract][Full Text] [Related]
6. Biochip analysis of prostate cancer.
Fan MQ; Wang PX; Feng JY; Xiao Y; Huang CB
Genet Mol Res; 2014 Jan; 13(1):152-9. PubMed ID: 24446298
[TBL] [Abstract][Full Text] [Related]
7. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
Sørensen KD; Ørntoft TF
Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer and the genomic revolution: Advances using microarray analyses.
Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE
Mutat Res; 2005 Aug; 576(1-2):66-79. PubMed ID: 15950992
[TBL] [Abstract][Full Text] [Related]
9. Integrative biology of prostate cancer progression.
Tomlins SA; Rubin MA; Chinnaiyan AM
Annu Rev Pathol; 2006; 1():243-71. PubMed ID: 18039115
[TBL] [Abstract][Full Text] [Related]
10. Genes differentially expressed in prostate cancer.
Eder IE; Bektic J; Haag P; Bartsch G; Klocker H
BJU Int; 2004 May; 93(8):1151-5. PubMed ID: 15142130
[TBL] [Abstract][Full Text] [Related]
11. Application of genomic technologies to human prostate cancer.
Li S; Bhamre S; Lapointe J; Pollack JR; Brooks JD
OMICS; 2006; 10(3):261-75. PubMed ID: 17069507
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
